Filing Details
- Accession Number:
- 0001192482-21-000211
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-03 20:01:50
- Reporting Period:
- 2018-01-12
- Accepted Time:
- 2021-03-03 20:01:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1267565 | Collegium Pharmaceutical Inc | COLL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1640701 | B Alison Fleming | C/O Collegium Pharmaceutical, Inc. 100 Technology Center Drive Stoughton MA 02072 | Chief Technical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-01-12 | 1,747 | $0.90 | 157,911 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-01-12 | 1,747 | $21.00 | 156,164 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-01-12 | 5,753 | $0.48 | 161,917 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-01-12 | 5,753 | $21.00 | 156,164 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-01-19 | 64 | $0.90 | 156,228 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-01-19 | 64 | $23.00 | 156,164 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-01-19 | 1,811 | $0.90 | 157,975 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-01-19 | 1,811 | $23.00 | 156,164 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-01-19 | 1,449 | $3.31 | 157,613 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-01-19 | 1,449 | $23.00 | 156,164 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-05-10 | 1,400 | $27.00 | 154,764 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-03-01 | 6,011 | $23.36 | 148,753 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Purchase) | Disposition | 2018-01-12 | 1,747 | $0.00 | 1,747 | $0.90 |
Common Stock | Stock Option (Right to Purchase) | Disposition | 2018-01-12 | 5,753 | $0.00 | 5,753 | $0.48 |
Common Stock | Stock Option (Right to Purchase) | Disposition | 2018-01-19 | 64 | $0.00 | 64 | $0.90 |
Common Stock | Stock Option (Right to Purchase) | Disposition | 2018-01-19 | 1,811 | $0.00 | 1,811 | $0.90 |
Common Stock | Stock Option (Right to Purchase) | Disposition | 2018-01-19 | 1,449 | $0.00 | 1,449 | $3.31 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
64 | 2019-04-23 | No | 4 | M | Direct | |
0 | 2023-01-24 | No | 4 | M | Direct | |
0 | 2019-04-23 | No | 4 | M | Direct | |
0 | 2020-02-26 | No | 4 | M | Direct | |
0 | 2021-02-08 | No | 4 | M | Direct |
Footnotes
- Certain transactions reported in this Form 4 are late due to an administrative error.
- The sales reported in these rows were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.
- The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2018.
- The sale reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2020.
- The option was fully vested and exercisable as of January 12, 2018.
- The option was fully vested and exercisable as of January 19, 2018.